Hedia
Hedia is a digital therapeutics company specializing in diabetes management through its flagship product, the Hedia Diabetes Assistant, a CE-marked Class IIb medical device designed to support insulin-requiring diabetes patients. The company offers a digital therapeutic solution that improves quality of life by helping patients achieve better health outcomes, including more stable blood glucose levels, through personalized insulin dosing and self-management tools. Hedia collaborates closely with patients, healthcare professionals, and industry partners, and its product is available in multiple European countries. The company is actively engaged in clinical research demonstrating reduced hypoglycemia risk and improved glycemic control, and it has a strong product pipeline with a next-generation product entering clinical testing. Hedia operates on a B2B model, providing access to its solution through healthcare professionals and partners with clinics, hospitals, and device manufacturers to enhance diabetes care.
Hedia
Hedia is a digital therapeutics company specializing in diabetes management through its flagship product, the Hedia Diabetes Assistant, a CE-marked Class IIb medical device designed to support insulin-requiring diabetes patients. The company offers a digital therapeutic solution that improves quality of life by helping patients achieve better health outcomes, including more stable blood glucose levels, through personalized insulin dosing and self-management tools. Hedia collaborates closely with patients, healthcare professionals, and industry partners, and its product is available in multiple European countries. The company is actively engaged in clinical research demonstrating reduced hypoglycemia risk and improved glycemic control, and it has a strong product pipeline with a next-generation product entering clinical testing. Hedia operates on a B2B model, providing access to its solution through healthcare professionals and partners with clinics, hospitals, and device manufacturers to enhance diabetes care.
TL;DR
Product: Hedia Diabetes Assistant — CE‑marked Class IIb medical device app that provides bolus insulin recommendations and self-management support
Clinical impact: Real‑world studies reported reduced hypoglycaemia risk and improved glycaemic control for new users
Go‑to‑market: B2B distribution via healthcare professionals, clinics, hospitals and partner channels across multiple European countries
Latest disclosed round: Feb 2024 — €3.0m (seed, per Dealroom)
Approximately 40 employees